Anixa Biosciences Stock Buy Hold or Sell Recommendation
| ANIX Stock | USD 3.30 0.01 0.30% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Anixa Biosciences is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Anixa Biosciences given historical horizon and risk tolerance towards Anixa Biosciences. When Macroaxis issues a 'buy' or 'sell' recommendation for Anixa Biosciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Anixa Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide. In addition, we conduct extensive research on individual companies such as Anixa and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Anixa Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Anixa |
Execute Anixa Biosciences Buy or Sell Advice
The Anixa recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Anixa Biosciences. Macroaxis does not own or have any residual interests in Anixa Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Anixa Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Moderately volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Anixa Biosciences Trading Alerts and Improvement Suggestions
| Anixa Biosciences had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 210 K. Net Loss for the year was (9.93 M) with profit before overhead, payroll, taxes, and interest of 127.5 K. | |
| Anixa Biosciences currently holds about 31.66 M in cash with (6.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.03. | |
| Anixa Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Anixa stock rises as Bitcoin added to treasury - Seeking Alpha |
Anixa Biosciences Returns Distribution Density
The distribution of Anixa Biosciences' historical returns is an attempt to chart the uncertainty of Anixa Biosciences' future price movements. The chart of the probability distribution of Anixa Biosciences daily returns describes the distribution of returns around its average expected value. We use Anixa Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Anixa Biosciences returns is essential to provide solid investment advice for Anixa Biosciences.
| Mean Return | 0.09 | Value At Risk | -5.74 | Potential Upside | 4.93 | Standard Deviation | 4.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Anixa Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Anixa Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Anixa Biosciences, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Anixa Biosciences back and forth among themselves.
| Shares | Bank Of New York Mellon Corp | 2024-06-30 | 73 K | Northern Trust Corp | 2024-09-30 | 71 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 69 K | Corecap Advisors, Llc | 2024-06-30 | 46.9 K | Tyler-stone Wealth Management | 2024-09-30 | 42 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 41.1 K | International Assets Investment Management, Llc | 2024-09-30 | 37.8 K | Ci Private Wealth Llc | 2024-06-30 | 37.4 K | Gemmer Asset Management Llc | 2024-06-30 | 35 K | Vanguard Group Inc | 2024-09-30 | 1.4 M | Davidson D A & Co | 2024-06-30 | 736.4 K |
Anixa Biosciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 2.9M | 22.7M | (16.8M) | (11.4M) | (10.3M) | (9.8M) | |
| Free Cash Flow | (6.2M) | (4.9M) | (6.5M) | (6.2M) | (5.6M) | (5.3M) | |
| Depreciation | 90.2K | 59.9K | 42K | 46K | 52.9K | 50.3K | |
| Other Non Cash Items | 148.1K | (5.4K) | 752K | 313K | 360.0K | 549.7K | |
| Net Income | (10.1M) | (13.1M) | (13.8M) | (9.9M) | (8.9M) | (9.4M) | |
| End Period Cash Flow | 6.4M | 29.1M | 12.4M | 915K | 1.1M | 999.6K | |
| Change To Inventory | (271.7K) | (64.3K) | 29K | 224K | 257.6K | 270.5K | |
| Investments | (290K) | (4.0M) | (10.7M) | (5.6M) | (5.0M) | (4.8M) | |
| Change To Netincome | 4.0M | 4.1M | 7.9M | 6.7M | 7.7M | 3.9M |
Anixa Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Anixa Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Anixa Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Anixa stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 4.27 | |
Ir | Information ratio | -0.01 |
Anixa Biosciences Volatility Alert
Anixa Biosciences shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Anixa Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Anixa Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Anixa Biosciences Fundamentals Vs Peers
Comparing Anixa Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Anixa Biosciences' direct or indirect competition across all of the common fundamentals between Anixa Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Anixa Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Anixa Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Anixa Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Anixa Biosciences to competition |
| Fundamentals | Anixa Biosciences | Peer Average |
| Return On Equity | -0.55 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Current Valuation | 86.01 M | 16.62 B |
| Shares Outstanding | 32.18 M | 571.82 M |
| Shares Owned By Insiders | 5.05 % | 10.09 % |
| Shares Owned By Institutions | 17.40 % | 39.21 % |
| Number Of Shares Shorted | 411.56 K | 4.71 M |
| Price To Earning | (51.83) X | 28.72 X |
| Price To Book | 4.89 X | 9.51 X |
| Price To Sales | 481.54 X | 11.42 X |
| Revenue | 210 K | 9.43 B |
| Gross Profit | 127.5 K | 27.38 B |
| EBITDA | (10.96 M) | 3.9 B |
| Net Income | (9.93 M) | 570.98 M |
| Cash And Equivalents | 31.66 M | 2.7 B |
| Cash Per Share | 1.03 X | 5.01 X |
| Total Debt | 175 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 22.01 X | 2.16 X |
| Book Value Per Share | 0.68 X | 1.93 K |
| Cash Flow From Operations | (6.21 M) | 971.22 M |
| Short Ratio | 3.58 X | 4.00 X |
| Earnings Per Share | (0.39) X | 3.12 X |
| Target Price | 8.5 | |
| Number Of Employees | 4 | 18.84 K |
| Beta | 0.85 | -0.15 |
| Market Capitalization | 106.19 M | 19.03 B |
| Total Asset | 25.52 M | 29.47 B |
| Retained Earnings | (228.2 M) | 9.33 B |
| Working Capital | 23.33 M | 1.48 B |
| Current Asset | 10.38 M | 9.34 B |
| Current Liabilities | 1.36 M | 7.9 B |
| Net Asset | 25.52 M |
Note: Acquisition by Catelani Michael of 500000 shares of Anixa Biosciences subject to Rule 16b-3 [view details]
Anixa Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Anixa . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Anixa Biosciences Buy or Sell Advice
When is the right time to buy or sell Anixa Biosciences? Buying financial instruments such as Anixa Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Anixa Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run JPY Crypto Assets Thematic Idea Now
JPY Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Japanese Yen. The JPY Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize JPY Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Anixa Stock Analysis
When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.